BRIEF-Immunovaccine launches DPX-NEO program to develop neoepitope immunotherapies

Thu May 5, 2016 7:46am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 5 (Reuters) - Immunovaccine Inc

* Launch of DPX-NEO program to develop neoepitope immunotherapies to expand immuno-oncology applications for depovax-based vaccines Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)